RAC 0.00% $1.66 race oncology ltd

Ann: Change in substantial holding, page-110

  1. 2,690 Posts.
    lightbulb Created with Sketch. 10348
    COH is not going down the pathway of commercialising Bisantrene so there is no conflict.

    All we can do in regards protecting RAC from a hostile TO is remain under the radar until such time as we are ready to shout out to the world. Australia is a long way from everywhere so it is not a bad place to hide. On top of this COH did a pretty good job of burying Bisantrene for us in their publications - very few people seem notice that CS1 is Bisantrene unless we tell them.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.